Romosuzumab and Low Sclerostin Levels Underlie CV Risk New research highlights potential safety concerns around women

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
Romosuzumab and Low Sclerostin Levels Underlie CV Risk New research highlights potential safety concerns around women taking romosozumab, a new anti-osteoporosis drug available on the NHS. https://t.co/tRGOXrm0Fk https://t.co/ebiRpCC81p
Links
https://bit.ly/3HPEBp1
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.